Bausch Health
BHC
349 hedge funds and large institutions have $4.76B invested in Bausch Health in 2019 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 103 increasing their positions, 116 reducing their positions, and 39 closing their positions.
41% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 39
34% more capital invested
Capital invested by funds: $3.54B → $4.76B (+$1.22B)
30% more funds holding in top 10
Funds holding in top 10: 10 → 13 (+3)
4% more funds holding
Funds holding: 334 → 349 (+15)
0.1% less ownership
Funds ownership: 54.86% → 54.76% (-0.1%)
11% less repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 116
19% less call options, than puts
Call options by funds: $354M | Put options by funds: $434M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$103M |
| 2 |
GCM
Glenview Capital Management
New York
|
+$65.1M |
| 3 |
Two Sigma Advisers
New York
|
+$33.7M |
| 4 |
Two Sigma Investments
New York
|
+$31M |
| 5 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
+$20.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$46.9M |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
-$30.3M |
| 3 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$29.7M |
| 4 |
Goldman Sachs
New York
|
-$23.7M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$23.5M |
BHC Hedge Fund Activity: Q1 2019 in Review
349 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2019, worth a combined $4.76B — up 34% from $3.54B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new BHC positions and 39 closed out — a net gain of 16 holders — while 103 added to existing stakes and 116 trimmed.
The largest buyer was Fidelity International, adding an estimated $103M. The largest seller was Citadel Advisors, cutting an estimated $46.9M.
- 349 institutional investors held Bausch Health (BHC) as of Q1 2019, up from 334 in Q4 2018.
- Funds reported $4.76B of Bausch Health stock for Q1 2019, up 34% quarter-over-quarter.
- 55 funds opened new Bausch Health positions in Q1 2019 and 39 closed out, a net change of +16 holders.
- The largest Bausch Health buyer in Q1 2019 was Fidelity International, an estimated $103M added.
- The largest Bausch Health seller in Q1 2019 was Citadel Advisors, an estimated $46.9M sold.
Based on aggregated 13F filings for Q1 2019.